RESUMO
Iodine is an essential micronutrient for the synthesis of thyroid hormones. The proper functioning of the thyroid axis is essential for the normal development of the nervous system, especially in the first trimester of gestation. The aim of the present study was to analyze the perinatal outcomes, anthropometry, and APGAR test scores of newborns and to relate them to maternal thyroid status. A total of 190 newborns participated in the study. No correlation was found between thyroid stimulating hormone (TSH) and maternal ioduria values in the first trimester of gestation with the weight or length of the newborn, or the APGAR score at one minute after birth. However, we found significant differences between the APGAR scores of children whose mothers had an iodine sufficiency level in the first trimester compared to the children of mothers with iodine deficiency. Similarly, the APGAR scores of children whose mothers had a TSH > 4 have significantly better APGAR scores than the children of mothers with a TSH < 4. Likewise, we found significant differences between the measurements of the newborns depending on whether their mothers smoked. The children of mothers who took iodine supplements or iodized salt obtained the highest APGAR score at one and five minutes after birth. It is essential to focus on recommending adequate consumption of iodine supplements and iodized salt prior to gestation and at least during the first trimester to achieve better fetal well-being.
Assuntos
Iodo/análise , Resultado da Gravidez , Primeiro Trimestre da Gravidez/sangue , Primeiro Trimestre da Gravidez/urina , Tireotropina/sangue , Adulto , Antropometria , Índice de Apgar , Suplementos Nutricionais/estatística & dados numéricos , Feminino , Humanos , Hipotireoidismo/sangue , Hipotireoidismo/urina , Recém-Nascido , Iodo/deficiência , Iodo/urina , Fenômenos Fisiológicos da Nutrição Materna , Gravidez , Complicações na Gravidez/sangue , Complicações na Gravidez/urina , Cuidado Pré-Natal/estatística & dados numéricos , Cloreto de Sódio na Dieta/análise , Glândula Tireoide/fisiopatologiaRESUMO
Background: Increasing evidence suggests that exposure to synthetic chemicals such as bisphenols and phthalates can influence fecundability. The current study describes associations of first trimester urinary concentrations of bisphenol A (BPA), BPA analogs, and phthalate metabolites with time to pregnancy (TTP). Methods: Among 877 participants in the population-based Generation R pregnancy cohort, we measured first trimester urinary concentrations of bisphenols and phthalates [median gestational age, 12.9 weeks (interquartile range, 12.1, 14.4)]. We used fitted covariate-adjusted Cox proportional hazard models to examine associations of bisphenol and phthalate concentrations with TTP. Participants who conceived using infertility treatment were censored at 12 months. Biologically plausible effect measure modification by folic acid supplement use was tested. Results: In the main models, bisphenol and phthalate compounds were not associated with fecundability. In stratified models, total bisphenols and phthalic acid were associated with longer TTP among women who did not use folic acid supplements preconceptionally [respective fecundability ratios per each natural log increase were 0.90 (95% CI, 0.81 to 1.00) and 0.88 (95% CI, 0.79 to 0.99)]. Using an interaction term for the exposure and folic acid supplement use showed additional effect measure modification by folic acid supplement use for high-molecular-weight phthalate metabolites. Conclusions: We found no associations of bisphenols and phthalates with fecundability. Preconception folic acid supplementation seems to modify effects of bisphenols and phthalates on fecundability. Folic acid supplements may protect against reduced fecundability among women exposed to these chemicals. Further studies are needed to replicate these findings and investigate potential mechanisms.
Assuntos
Compostos Benzidrílicos/urina , Fenóis/urina , Ácidos Ftálicos/urina , Primeiro Trimestre da Gravidez/urina , Tempo para Engravidar/fisiologia , Adulto , Estudos de Coortes , Suplementos Nutricionais , Feminino , Fertilidade , Ácido Fólico/administração & dosagem , Humanos , Cuidado Pré-Concepcional/métodos , Gravidez , Modelos de Riscos ProporcionaisRESUMO
The objective of this study was to determine the effectiveness of routine iodine supplementation among pregnant women in areas of high prevalence of an iodine insufficiency, using WHO criteria to determine the iodine status. A longitudinal study was conducted on pregnant women attending antenatal care at a tertiary hospital. The urine iodine concentration was measured in the first trimester and after 150 µg of iodine supplementation in the third trimester. A total of 327 pregnant women met the inclusion criteria with a complete follow-up. The prevalence of an iodine insufficiency was significantly lower in the third trimester, when compared to the first trimester (21.41% vs 55.35%, p < .001). However, 21.4% of cases still had an iodine insufficiency and 35.17% had an 'above-requirement' in the third trimester. In the areas of high prevalence of iodine insufficiency, an iodine supplementation significantly reduces the number of women with insufficiency; however, it was associated with unnecessarily high UICs, leading to the risk of excess iodine. Impact statement What is already known on this subject: Iodine insufficiency is highly prevalent in many geographical areas. Half of the pregnant women in the northern part of Thailand had an iodine insufficiency in the first trimester. What do the results of this study add: Iodine supplementation (daily 150-mcg of potassium iodide) could significantly reduce the number of women with the insufficiency. About one-fifth of women still had an iodine insufficiency in spite of iodine supplementation. Universal supplementation could be associated with unnecessarily high UICs, potentially at risk of iodine excess. What are the implications of these findings for clinical practice and/or further research: Physicians should guard against the occurrence of adverse effect from an iodine excess when there is routine iodine supplementation for pregnant women. Further study is required to establish the best strategy for an iodine supplementation in pregnancy.
Assuntos
Suplementos Nutricionais , Iodo/deficiência , Iodo/uso terapêutico , Complicações na Gravidez/terapia , Adulto , Feminino , Humanos , Iodo/urina , Estudos Longitudinais , Gravidez , Complicações na Gravidez/epidemiologia , Complicações na Gravidez/urina , Primeiro Trimestre da Gravidez/urina , Terceiro Trimestre da Gravidez/urina , Prevalência , Estudos Prospectivos , Tailândia/epidemiologia , Resultado do TratamentoRESUMO
BACKGROUND: Arsenic has immunomodulatory properties and may have the potential to alter susceptibility to infection in humans. OBJECTIVES: We aimed to assess the relation of arsenic exposure during pregnancy with immune function and hepatitis E virus (HEV) infection, defined as seroconversion during pregnancy and postpartum. METHODS: We assessed IgG seroconversion to HEV between 1st and 3rd trimester (TM) and 3 months postpartum (PP) among 1100 pregnancies in a multiple micronutrient supplementation trial in rural Bangladesh. Forty women seroconverted to HEV and were matched with 40 non-seroconverting women (controls) by age, parity and intervention. We assessed urinary inorganic arsenic plus methylated species (∑As) (µg/L) at 1st and 3rd TM and plasma cytokines (pg/mL) at 1st and 3rd TM and 3 months PP. RESULTS: HEV seroconverters' urinary ∑As was elevated throughout pregnancy. Non-seroconverters' urinary ∑As was similar to HEV seroconverters at 1st TM but declined at 3rd TM. The adjusted odds ratio (95% confidence interval) of HEV seroconversion was 2.17 (1.07, 4.39) per interquartile range (IQR) increase in average-pregnancy urinary ∑As. Increased urinary ∑As was associated with increased concentrations of IL-2 during the 1st and 3rd TM and 3 months PP among HEV seroconverters but not non-seroconverters. CONCLUSIONS: The relation of urinary arsenic during pregnancy with incident HEV seroconversion and with IL-2 levels among HEV-seroconverting pregnant women suggests arsenic exposure during pregnancy may enhance susceptibility to HEV infection.
Assuntos
Arsênio/urina , Poluentes Ambientais/urina , Hepatite E/epidemiologia , Adolescente , Adulto , Anticorpos Antivirais/sangue , Bangladesh/epidemiologia , Estudos de Casos e Controles , Citocinas/sangue , Suscetibilidade a Doenças , Exposição Ambiental/análise , Feminino , Hepatite E/sangue , Hepatite E/imunologia , Hepatite E/urina , Vírus da Hepatite E/imunologia , Humanos , Imunoglobulina G/sangue , Gravidez/sangue , Gravidez/urina , Primeiro Trimestre da Gravidez/sangue , Primeiro Trimestre da Gravidez/urina , Terceiro Trimestre da Gravidez/sangue , Terceiro Trimestre da Gravidez/urina , Soroconversão , Adulto JovemRESUMO
Low iodine intake during pregnancy may cause thyroid dysfunction in pregnant women and their newborn. In the present study, iodine status among a nation-wide representative sample of Belgian pregnant women in the first and third trimester of pregnancy was determined, and determinants of iodine status were assessed 1 year after the introduction of bread fortified with iodised salt. The women were selected according to a multistage proportionate-to-size sampling design. Urine samples were collected and a general questionnaire was completed face to face with the study nurse. The median urinary iodine concentration (UIC) among pregnant women (n 1311) was 124.1mg/l and 122.6 mg/g creatinine when corrected for urinary creatinine. The median UIC in the first trimester (118.3 mg/l) was significantly lower than that in the third trimester (131.0 mg/l) but significantly higher than among non-pregnant women (84.8 mg/l). Iodine-containing supplement intake was reported by 60.8% of the women and 57.4% of the women took this supplement daily. The risk of iodine deficiency was significantly higher in younger women, in women not taking iodine-containing supplements, with low consumption of milk and dairy drinks and during autumn. Women with a higher BMI had a higher risk of iodine deficiency but the risk was lower in women who reported alcohol consumption. The median UIC during pregnancy indicates iodine deficiency in Belgium and some women are at a higher risk of deficiency. The current low iodine intake in women of childbearing age precludes the correction of iodine deficiency in pregnant women supplemented with multivitamins containing 150 mg iodine as recommended.
Assuntos
Creatina/urina , Alimentos Fortificados , Iodo/deficiência , Cloreto de Sódio na Dieta , Adulto , Bélgica/epidemiologia , Estudos Transversais , Deficiências Nutricionais/epidemiologia , Inquéritos sobre Dietas , Suplementos Nutricionais , Feminino , Humanos , Iodo/administração & dosagem , Iodo/urina , Modelos Logísticos , Gravidez , Primeiro Trimestre da Gravidez/urina , Terceiro Trimestre da Gravidez/urina , Valores de Referência , Risco , Estatísticas não Paramétricas , Vitaminas/administração & dosagemRESUMO
Adequate maternal iodine intake is essential during pregnancy for the development of the foetus. To assess the extent of iodine insufficiency and its association with household iodized salt in rural Bangladesh, we measured urinary iodine and household salt iodine content among pregnant women in early (≤16 weeks, n = 1376) and late (≥32 weeks, n = 1114) pregnancy. Salt (â¼20 g) and a spot urine sample (â¼10 mL) were collected from women participating in a randomized, placebo-controlled trial of vitamin A or beta-carotene supplementation in rural northwestern Bangladesh during home visits in early and late pregnancy. Salt iodine was analyzed by iodometric titration, and urinary iodine by the Ohashi method. Almost all salt samples had some detectable iodine, but over 75% contained <15 ppm. Median (interquartile range) urinary iodine concentrations were 66 (34-133) and 55 (28-110) µg L⻹ in early and late pregnancy, respectively; urinary iodine <150 µg L⻹ was found in â¼80% of women at both times in pregnancy. Although the risk of iodine insufficiency declined with increasing iodine content of household salt (P for trend <0.05), median urinary iodine did not reach 150 µg L⻹ until iodine in household salt was at least 32 ppm and 51 ppm during early and late pregnancy, respectively. Despite a national policy on universal salt iodization, salt iodine content remains insufficient to maintain adequate maternal iodine status throughout pregnancy in rural northern Bangladesh. Alternative measures like direct iodine supplementation during pregnancy could be considered to assure adequate iodine status during this high-risk period of life.
Assuntos
Características da Família , Iodo/deficiência , Iodo/urina , Estado Nutricional , Fenômenos Fisiológicos da Nutrição Pré-Natal , Saúde da População Rural , Adulto , Bangladesh/epidemiologia , Estudos Transversais , Método Duplo-Cego , Feminino , Humanos , Iodo/administração & dosagem , Iodo/análise , Iodo/química , Pacientes Desistentes do Tratamento , Gravidez , Primeiro Trimestre da Gravidez/urina , Terceiro Trimestre da Gravidez/urina , Risco , Cloreto de Sódio na Dieta/administração & dosagem , Adulto JovemRESUMO
OBJECTIVE: To assess intertrimester and seasonal variations in urinary iodine concentration (UIC) among pregnant women. PATIENTS AND MEASUREMENTS: Pregnant Tehranian women, with no history of thyroid ablation or consumption of thyroid-affecting medication were selected consecutively from November 2004 to November 2006. Morning spot urine samples were collected from each participant during the first, second and third trimesters of pregnancy. Of 466 participants, 298 completed the study in all three trimesters of pregnancy. UIC < 150, 150-250, and > 250 microg/l indicated low, adequate, and high levels, respectively. UIC was measured using a modified Sandell-Kolthoff digestion method. RESULTS: The pregnant women were aged 25.0 +/- 5.0 (range 16-48) years. Median UIC did not show seasonal fluctuations during pregnancy. However, median (range) UIC was 193 (19-840), 159 (16-640), and 141 (16-400) microg/l in the first, second and third trimesters of pregnancy, respectively (P < 0.0001). Frequency distributions of low, adequate and excessive UIC were 33.2, 31.2 and 35.6% in the first trimester, 46.0, 28.9 and 25.2% in the second trimester, and 53.4, 30.9 and 15.8% in the third trimester of pregnancy, respectively (P < 0.0001). Women with UIC < 150 were more frequently represented in the second vs. the first (P = 0.043; odds ratio 1.49, 95% confidence interval 1.012-2.213) and in the third vs. the first (P = 0.013; odds ratio 1.62, 95% confidence interval 1.108-2.379) trimesters of pregnancy than the 150-250 microg/l group were. UIC decreased throughout pregnancy in all seasons. CONCLUSIONS: Iranian national salt iodization may prevent seasonal fluctuations of UIC but does not maintain median UIC within adequate and recommended ranges throughout pregnancy. Extra iodine supplementation during pregnancy is recommended.